26. Asthma management from the physicians’ perspectives: Results from a national survey in Vietnam
Main Article Content
Abstract
Implementation of Global Initiative for Asthma (GINA) recommendations in asthma management and prevention remains a challenge in many countries including Vietnam. We investigate Vietnamese physicians’ behaviors in treatment for asthma management and how their current clinical practices correlate with recent GINA recommendations by using a standardized questionnaire. Results: From the physicians’ perspectives, their main treatment goals were symptom control and overall control for mild asthma, and exacerbation reduction for moderate-severe asthma. Most physicians chose regular ICS-containing regimens as a preferred maintenance treatment option for mild and moderate asthma. MART was aware by most physicians, however, correct prescribing rates for MART remained low. Although the personalized treatment recommended by GINA and national guidelines have been implemented in Vietnam, further training on asthma guidelines for physicians is necessary to improve the accuracy of treatment options.
Article Details
Keywords
Asthma management, GINA, physicians’ perspectives, Treatment goals, MART, PRD, APPaRENT
References
2. Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet (London, England). 2018; 391(10122): 783-800.
3. Lai CK, Beasley R, Crane J, Foliaki S, Shah J, Weiland S. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2009; 64(6): 476-483.
4. Lai CK, De Guia TS, Kim YY, et al. Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. The Journal of allergy and clinical immunology. 2003; 111(2): 263-268.
5. Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ primary care respiratory medicine. 2014; 24: 14009.
6. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention (2022 update). 2022.
7. Chapman KR, An L, Bosnic-Anticevich S, et al. Asthma patients’ and physicians’ perspectives on the burden and management of asthma. Respiratory Medicine. 2021; 186.
8. O’Byrne PM, FitzGerald JM, Bateman ED, et al. Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma. New England Journal of Medicine. 2018; 378(20): 1865-1876.
9. Lin J, Xing B, Chen P, et al. Chinese expert consensus-based guideline on assessment and management of asthma exacerbation. Journal of Thoracic Disease. 2019; 11(12): 4918-4935.
10. K.R. Chapman SB-A, M.C. Cano, Abhijith. PG,. Exploring Use of Regular ICS/LABA Dosing in Moderate to Severe Asthma Among Physicians: Results From the Asthma Patients’ and Physicians’ peRspectiveson the burden and managemENTof asthma studies (APPaRENT1 & 2). American Thoracic Society Meeting; 2022; San Francisco, CA.
11. Society of Asthma and Allergy and Clinical Immunology in Ho Chi Minh City. ACOCU Information. 2022; https://www.hoihendumdlstphcm.org.vn/index.php/gioi-thieu.
12. O’Byrne PM, Jenkins C, Bateman ED. The paradoxes of asthma management: time for a new approach? European Respiratory Journal. 2017; 50(3): 1701103.
13. Network TGA. The Global Asthma Report 2018. 2018 Mar 19, 2022.
14. Kearns N, Williams M, Bruce P, et al. Single dose of budesonide/formoterol turbuhaler compared to salbutamol pMDI for speed of bronchodilator onset in asthma: a randomised cross-over trial. Thorax. 2022.
15. Caminati M, Magnoni MS, Rizzi A, et al. Asthma management among different specialists: results from a national Italian survey. European annals of allergy and clinical immunology. 2014; 46(2): 74-82.
16. Althubaiti A. Information bias in health research: definition, pitfalls, and adjustment methods. Journal of multidisciplinary healthcare. 2016; 9:211-217.